ReviewCurrent urology reports2015
Lymph node staging in prostate cancer.
Review in Current urology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Diagnostic accuracy of MRI radiomics in predicting lymph node metastasis in prostate cancer: A systematic review.European journal of radiology open · 2025Review
- MRI-detected extranodal extension as a marker of prostate cancer aggressiveness.European radiology · 2025Article
- Article
- Radiological Assessment of Different Retroperitoneal Lymph Node Measurements in Stage 1 Testicular Cancer Patients: Impact on Clinical Stage and Treatment.Journal of clinical medicine · 2024Article
- Article
- Article
- Comparison of Multiparametric MRI, [Cancers · 2023Article
- Beyond diagnosis: is there a role for radiomics in prostate cancer management?European radiology experimental · 2023Review
- Current Opinion on the Use of Magnetic Resonance Imaging in Staging Prostate Cancer: A Narrative Review.Cancer management and research · 2022Review
- Development and validation of the 3D U-Net algorithm for segmentation of pelvic lymph nodes on diffusion-weighted images.BMC medical imaging · 2021Article
- Associations between LncRNADiagnostics (Basel, Switzerland) · 2021Article
- A narrative review of pelvic lymph node dissection in prostate cancer.Translational andrology and urology · 2020Review
- Prevalence and clinical significance of incidental findings on multiparametric prostate MRI.La Radiologia medica · 2020Article
- Metastases in Prostate Cancer.Cold Spring Harbor perspectives in medicine · 2019Review
- Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review.Translational andrology and urology · 2018Review
- Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer.Translational andrology and urology · 2018Review
- Article
- The impact of [Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2018Article
- PET imaging for lymph node dissection in prostate cancer.World journal of urology · 2017Review
- Functional nanoparticles for magnetic resonance imaging.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Nodal staging is important in prostate cancer treatment. While surgical lymph node dissection is the classic method of determining whether lymph nodes harbor malignancy, this is a very invasive technique. Current noninvasive approaches to identifying malignant lymph nodes are limited. Conventional imaging methods rely on size and morphology of lymph nodes and have notoriously low sensitivity for detecting malignant nodes. New imaging techniques such as targeted positron emission tomography (PET) imaging and magnetic resonance lymphography (MRL) with iron oxide particles are promising for nodal staging of prostate cancer. In this review, the strengths and limitations of imaging techniques for lymph node staging of prostate cancer are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.